Nuvation Bio NUVB Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months)
Available-for-Sale Debt Securities - Unrealized Loss Position (>=12 Months) at other companies
Other financials
Where this comes from
Reported directly by Nuvation Bio in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger.
The official record: Nuvation Bio’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Questions, answered.
- What is Nuvation Bio's available-for-sale debt securities - unrealized loss position (>=12 months)?
- Nuvation Bio (NUVB) reported available-for-sale debt securities - unrealized loss position (>=12 months) of $0 in Q4 2025.
- How has Nuvation Bio's available-for-sale debt securities - unrealized loss position (>=12 months) changed year-over-year?
- Nuvation Bio's available-for-sale debt securities - unrealized loss position (>=12 months) decreased by 100.0% year-over-year, from $55.01M to $0.
- What does available-for-sale debt securities - unrealized loss position (>=12 months) mean?
- This measures the fair value of available-for-sale debt securities that have remained in an unrealized loss position for a year or more. Persistent losses in this category may indicate potential credit quality issues or long-term market headwinds for the underlying securities.